ReShape Lifesciences shareholders approve merger with Vyome Therapeutics

2 hours ago 1

ReShape Lifesciences (NASDAQ:RSLS) shareholders approved all proposals for the merger with Vyome Therapeutics.
The merger is expected to be effective by Friday, August 15, 2025.
The combined company will be named Vyome Holdings.
Shares will trade on Nasdaq under the new ticker symbol "HIND."
Source: Press release

Recommended For You